#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on Ceralasertib and Durvalumab for Patients with Advanced Melanoma Resistant to PD-(L)1 Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Poland Spain

  • Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Italy +4

  • Study of MaaT013 (Fecal Transplantation) Combined with Ipilimumab and Nivolumab in Patients with Previously Untreated Melanoma

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    Austria France Germany Greece Ireland Italy +2

  • Study on Atezolizumab and Tiragolumab for Patients with Head and Neck Cancer, Metastatic Melanoma, and Other Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Tebentafusp and Drug Combination for Patients with Advanced Uveal Melanoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Italy Poland Spain

  • Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Poland

  • Study on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Italy